Cohort of Repeat Donor Experiences (CORE) Study
Starting soon
Conditions studied: Health Effects (Ferritin Levels, CRP Levels, iGg Levels, Self-reported Health)
In brief
The Plasma Protein Therapeutics Association (PPTA) sponsors the Cohort of Repeat Donor Experiences (CORE) Study. This is a prospective, observational cohort study that will follow Source Plasma donors for up to 2 years during the main study (anticipated to begin in summer 2026) and up to 3 months during the pilot launching in mid-March 2026. This study aims to confirm a lack of negative health effects Source Plasma donors may experience as a result of frequent plasmapheresis. The study will use data obtained through self-report surveys for the duration of the study along with periodic whole blood sample collections to test for CRP, ferritin, and IgG.
Key facts
- Study ID
- NCT07543965
- Run by
- Westat
- People needed
- 2090
- Starts
- 2026-04-06
- Expected to finish
- 2029-04-30
- Last updated by the study team
- 2026-04-22
Who can join
Age: 18 and older, up to 74. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Aged 18-74;
- Meet health and medical history requirements for being a plasma donor per eCFR::21 CFR 630.10 Subpart B -- General donor eligibility requirements;
- Willing to provide phone number and mailing address; has access to internet-enabled smartphone device;
- Plans to remain within local area during study duration; has not donated whole blood within past 12 months;
- Does not have permanent deferral;
- Has not donated plasma more than once at a non-participating plasma center;
- Another member of their household is not enrolled.
Where it is running
- ADMA Biocenters — Dallas, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.